MedTrace Logo

The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans

NCT05349916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-04-27

No results posted yet for this study

Summary

The main objective of the current study is to investigate whether consumption of soluble fibers (isomaltodextrin \[IMD\], partially digestible maltodextrin) and RS4 starch will lower postprandial glycemia as well as postprandial insulin in human subjects with relatively high fasting blood glucose, when consumed with a specific amount of digestible carbohydrate (rice porridge). The primary outcome of the study is the effect of fibers on postprandial blood glucose, whereas the secondary outcome will be its effect on postprandial blood insulin.

Conditions

  • Postprandial Hyperglycemia
  • Type2 Diabetes
  • Blood Sugar; High

Interventions

OTHER

Control

300 g rice porridge + 150 ml drinking water

OTHER

Isomaltodextrin Low Dose

300 g rice porridge + (5 g IMD in 150 ml drinking water)

OTHER

Isomaltodextrin High Dose

300 g rice porridge + (10 g IMD in 150 ml drinking water)

OTHER

GPC partially digestible maltodextrin

300 g rice porridge + (15 g GPC fiber in 150 ml drinking water)

OTHER

Resistant Starch Type 4

300 g rice porridge + (15 g RS4 starch in 150 ml drinking water)

Sponsors & Collaborators

  • Grain processing corporation

    collaborator UNKNOWN

  • Purdue University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-07
Primary Completion
2022-03-09
Completion
2022-03-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349916 on ClinicalTrials.gov